Cargando…
Survival and late effects of hematopoietic cell transplantation in patients with thalassemia major
In this retrospective study, we evaluated long-term survival and late effects in 137 patients affected by thalassemia major (TM) who received an allogeneic hematopoietic cell transplantation (HCT). Median age at HCT was 10.1 years. After a median follow-up of 30 years, 114 (83.2%) patients are livin...
Autores principales: | Santarone, Stella, Angelini, Stefano, Natale, Annalisa, Vaddinelli, Doriana, Spadano, Raffaele, Casciani, Paola, Papola, Franco, Di Lembo, Enza, Iannetti, Giovanni, Di Bartolomeo, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400570/ https://www.ncbi.nlm.nih.gov/pubmed/36002533 http://dx.doi.org/10.1038/s41409-022-01786-4 |
Ejemplares similares
-
Tongue cancer following hematopoietic cell transplantation for Fanconi anemia
por: Di Bartolomeo, Mattia, et al.
Publicado: (2022) -
Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience
por: Rahal, Ilhem, et al.
Publicado: (2018) -
Response to BNT162b2 Sars-Cov-2 Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant
por: Saraceni, Francesco, et al.
Publicado: (2021) -
Fatigue as Mediator Factor in PTSD-Symptoms after Allogeneic Hematopoietic Stem Cell Transplantation
por: Di Francesco, Giulia, et al.
Publicado: (2023) -
The Leading Role of Brain and Abdominal Radiological Features in the Work-Up of Anti-NMDAR Encephalitis in Children: An Up-To-Date Review
por: Guarino, Miriana, et al.
Publicado: (2023)